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Introduction: Generic medicines are produced by multiple manufacturers hence, are usually cheaper than innovator brands and 
therefore save costs on medicines. Many physicians oppose brand substitution, believing generic medicines to be inferior to their 
originator counterparts. Physicians’ belief about generic medicines and factors affecting generic prescribing in Ethiopia are poorly 
investigated. 
Objective: To assess the physicians’ belief about generic medicines and to identify factors affecting generic medicines prescribing 
in private health facilities, Mekelle, Northern Ethiopia. 
Materials and Methods: An institution based cross-sectional study was conducted enrolling all physicians working in private health 
facilities. The data were collected from January 2016 to March 2016. Data were collected using self-administered structured 
questionnaires measuring generic medicines belief of physicians using a Likert scale of 1–5. Data were then entered into SPSS 
version 20 for analysis.  
Results: Of the fifty-six physicians approached in this study, 50 (89.2% response rate) questionnaires were included in the analysis. 
Nearly three-fourth (72%) of the physicians claimed that they always prescribe generic medicines. More than half (55.3) of the 
respondents beliefs generic medicines have different active ingredients than a brand innovator. Almost equal percentage (52% and 
54%) of the Physicians disagreed with brand medicines were safer than generic medicines and prescribing generic due to the 
complicated health problem of the patient respectively. Around two third (67.5%) of physicians reported that quality profile of 
medicine was a major reason for prescribing generic medicines. Moreover, availability of medicines in pharmacies and low cost of 
medicines were the main reasons for prescribing generic medicines with 58.1% and 52.4% respectively.  
Conclusion: The majority of physicians do not have a positive perception of generic medicines and a significant portion of the 
physician’s belief brand medicines safer and effective than generic counterparts. The availability of medicines in pharmacies, low 
cost of medicines and purchasing power of the patients are major factors affecting generic medicines prescribing. 
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INTRODUCTION  
A generic medicine is a product that can be 
interchangeable with the innovator product, which does 
not need a license from the innovator, and manufactured 
after the expiration of the patent or other exclusivity 
rights.
1-3 
In order to be approved, a generic medicine 
should be bioequivalent to the originator product, and 
must be the same in terms of strength, safety and 
quality
1, 4, 5
 while generic medicines could differ from 
their equivalent branded medicine in their color, size, 
shape and excipient ingredients, they must be able to 
demonstrate bioequivalence to the originator medicine in 
terms of bioavailability and the rate of absorption.
2, 6
 
Generic medicines are produced by multiple 
manufacturers hence, are usually cheaper than innovator 
brands and therefore save costs on medicines.
1,4,5 
 Study 
conducted in 17 developing countries reported an 
average of 9–89% expenditure could be saved by each 
country in private sector purchases by switching from 
originator brands to lowest-priced generics.
5
 Generic 
formulations offer the same therapeutic effect as branded 
medicines at a much more lowest price.
7 
Because of this, 
generic drugs have been dramatically popular as a 
method to reduce pressure on drug budgets, and they 




Many physicians oppose brand substitution, believing 
generic medicines to be inferior to their originator 
counterparts.
9
 In the UK, there was strong opposition 
when planned to introduce generic replacement into UK 
primary care.
10
 However, Public and private third-party 
payers and health care regulatory authorities 
increasingly encourage or obligate the use of generics 




The use of generics has increased significantly in the last 
two decades. Although generic prescribing by 
physicians, is advocated in most countries, the extent to 
which this is put to practice differs significantly as do 
monitoring and evaluation by health insurance 
companies
16,17 
and generic substitution laws.
18
 Generic 
drug prescription policies differ from country to country 
globally. The practice of generic medicines prescribing 
and substitution in developing countries has been 
controversial among healthcare professionals, 
principally due to issues on quality, safety and 
efficacy.
19 
The use of generics is therefore often 
promoted in the public and private sectors to save 
medicine expenditure, and enhance product availability 
and client access.
20 
In Ethiopia, clinical practice 
guidelines enforce a prescription should be using generic 
names of the medicine(s).
21
 
Private health care at present, accounts for over two 
thirds of total healthcare expenditure
22,23
 and over 70% 
of the entire expenditure on pharmaceuticals.
24
 
Currently, there is limited prescribing of generics 
specifically in the private sector, for instance. a study 
revealed over 90% of patients in the private sector 
typically demand originators and prices of generics vary 
from 0.2 to 7.02 times that of international market 
reference prices among a basket of products.
23,25 
The prescribing behavior of physicians is considered to 
be crucial for generic utilization as they determine 
whether their patients require branded drugs or generic 
drugs.
26
 A generic medicine may not always be suitable 
for the patient.
27
 Several factors may significantly 
influence the physicians prescribing behavior such as the 
trust and the quality image of the manufacturer 
company.
28
 Physicians’ prescribing practice can also be 
influenced by pharmaceutical manufacturers through a 
variety of incentives such as high-end education 
programs or even some cash payment for prescriptions.
29
 
In addition, free samples and gifts can also be provided
30
 
so that a targeted drug’s name stays topmost in 
subconscious mind of the prescribers.
31
 Therefore, these 
incentives may indirectly influence the patients, by 
encouraging them to use costly originator products 
instead of in the same way effective, lower-cost 
generics.
32
 Globally, physicians are much more 
responsive to arguments about a drug's effectiveness 
than about its price.
33
 Physicians with better education, 
better training on rational drug use and better possession 




Physicians’ belief about generic medicines and factors 
affecting generic prescribing in Ethiopia are poorly 
investigated. Therefore, this study narrows the 
knowledge gap and the findings of the current study 
assist policy makers regarding generic prescribing in the 
future. The main objective of the study was to assess 
physicians’ belief about generic medicines and to 
identify factors affecting generic medicines prescribing 
in private health facilities, Mekelle, Ethiopia. 
METHODS AND MATERIALS 
The study was conducted in Mekelle city is main city of 
Tigray regional state, Ethiopia. Mekelle city is found at 
783 Km Northeast of Addis Ababa, which is the capital 
of Ethiopia. Mekelle city has one comprehensive 
specialized referral hospital, three general hospitals, 
three private hospitals, sixty-three private clinics and 
nine health centers. This institution-based cross sectional 
study was conducted from January 13, 2016 to March 
20, 2016. 
All physicians (56) working in private health facilities 
were considered as the study population. Physicians 
inclusion criteria were experience of 6 months or greater 
in Mekelle city, whereas the exclusion criteria were 
unwilling to participate in the study and unable to fill out 
the questionnaire.  
Data were collected using self-administered 
questionnaire. The questionnaire had three different 
sections. The first part of the questions addresses socio 
demographic characteristics of respondents which 
followed by questions about generic medicines belief 
and finally questions about the reason for prescribing 
generic medicines were included. One day training was 
given to data collectors and supervisors on how to 
collect data from the respondents.  Pretest was done on 
5% of the questionnaires at Quiha hospital, which were 
not the part of the study area and the result was not 
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included. Daily on the spot-checking of filled 
questionnaires for errors or any incompleteness was 
done by holding daily discussions among data collectors.  
The collected data were entered, cleaned and analyzed 
using SPSS version 20 statistical software. Frequencies 
and percentages were done for categorical variables. The 
normality of the population distribution was checked 
with histogram for continuous variables, for non-
normally distributed population the measure of central 
tendency (median) and a measure of dispersion (inter-
quartile range) was reported. 
Ethical clearance was obtained from Ethical Review 
Committee  of College of Health Sciences, Mekelle 
University. Written permission was also obtained from 
the Tigray Regional Health Bureau, Mekelle city Health 
office and informed consent was obtained from 
individual respondents. Participants’ information which 
gets from the questionnaires was kept confidential. 
Participants were also informed that participation was 
voluntary and they had right to refuse answering to any 
of the questions. 
RESULTS 
Of the 56 physicians working in a private health facility, 
50 of them were voluntary to participate in this study 
which made a response rate of 89.2%. Forty six (92%) 
of physicians were males with Median age of 32 years 
and with an Inter quartile range (IQR) of 12. Among all 
respondents 28 (56%) and 22 (44 %) were married and 
were specialists respectively. Nearly half (48%) of the 
study participants have had an experience of less than or 
equal to five years (Table 1). 
 
Figure 1: Physician (N = 50) response to always prescribe 
generic medicines in Private Health Facilities, Mekelle, 
Ethiopia, 2016 
Table 1: Socio-demographic characteristics of the 
Physicians in Private Health Facilities, Mekelle, 




Age (years)   
≤30 22 44.0 
31-40 17 34.0 
≥41 11 22.0 
Sex   
Male 46 92.0 
Female 4 8.0 
Marital status   
Married 28 56.0 
Single 22 44.0 
Educational status   
First degree (GP) 19 38.0 
Specialist 22 44.0 
Resident 9 18.0 
Experience (years)   
≤5 24 48.0 
6-15 18 36.0 
≥16 8 16.0 
 
Approximately three fourth (72%) of the physicians 
reported that they  always prescribe generic medicines 
while 28% of respondents were neutral or disagree to 
prescribe generics (Figure 1). 
 
Above half (55.3%) of the study participants reported 
that they believe that generic medicines have different 
active ingredients to that of  brand medicines and almost 
equal percentage (52% and 54%) of the respondents 
disagreed with brand medicines were safer than generic 
medicines and prescribing generic due to the 
complicated health problem of the patient respectively. 
Twenty six (52%) of the physicians believed that locally 
produced drugs were equally effective as the brand 
products. In addition, nearly three fourth (72%) of the 
study participants strongly disagreed or disagreed with 
the concept of brand medicines were cost effective than 
generic counterparts (Table 2). 
Table 2: Physicians belief about generic medicines in Private Health Facilities, Mekelle, Ethiopia, 2016 (N=50). 
S.
N. 
Statement  N (%) 
Strongly 
disagree 
Disagree  Neutral  Agree  Strongly 
agree 
1 Generic  medicines have different active ingredients 
than brand medicines   
4(10.5) 9(23.7) 4(10.5) 15(39.5) 6(15.8) 
2 Brand medicines are safer than generic medicines 8(16) 18(36) 10(20) 13(26) 1(2) 
3 Locally produced medicines are equally effective as 
original brand medicines  
3(6) 14(28) 6(12) 22(44) 5(10) 
4 Generic medicines are similar with brand counterpart 
in all aspects 
16(45.7) 12(34.5) 3(8.6) 2(5.7) 2(5.7) 
5 Brand medicines are cost effective than generic 
medicines  
10(20) 26(52) 6(12) 6(12) 2(4) 
6 Brand medicines are prescribed for complicated 
conditions 






Strongly disagree Disagree Neutral Agree Strongly agree 
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Around two third (67.5%) of physicians claimed that 
quality profile of medicine were major reason for 
prescribing generic medicines while the majority of 
respondents declared that they disagreed with the 
statement “I prescribe generic medicines due to peer 
norms”. Approximately equal (58.1 and 52.4) percent of 
respondents agreed with availability of medicines in 
pharmacies and low cost of medicines were among the 
main reasons for prescribing generic medicines (Table 
3). 
 
Table 3: The main reasons of physicians for prescribing generic medicines in Private Health Facilities, Mekelle, 
Ethiopia, 2016 (N=50). 
S.N. Reason for prescribing generic drug  N (%) 
Strongly 
disagree 
Disagree  Neutral  Agree  Strongly 
agree 
1 Due to peer norms 7(20) 18(51.4) 3(8.6) 4(11.4) 3(8.6) 
2 Quality profile of the medicine 1(2.5) 3(7.5) 9(22.5) 22(55) 5(12.5) 
3 Availability of the medicines in 
pharmacies 
2(4.5) 7(15.9) 5(11.4) 24(54.5) 6(13.6) 




Figure 2: Response of physicians towards influence of medical 
representatives on prescribing brand medicines in Private 
Health Facilities, Mekelle, Ethiopia, 2016 (N=50). 
More than half (52%) of the study participants believed 
that they were prescribed brand medicines on the basis 
of purchasing power of the patients. Above half 27 
(58%) of the physicians strongly agreed or agreed that 
they prescribe brand medicines due to the influence of 
medical representative (Figure 2). 
Chi-square test was done to see the association between 
the dependent and various independent variables by 
considering p-value of 5% significant level. As table 3 
indicated the proportion of male physicians who 
prescribe generic drugs was 34(73.9%) and the 
proportion of female physicians who prescribe generic 
drugs was 2(50.0%) with p-value of 0.307.The 
proportion of general practitioners, specialists and other 
professionals to prescribe generic medicines was 
16(44.4%), 15(41.7%) and 5(13.9%) respectively with a 
p-value of 0.25 (Table 4). 
 
Table 4: Association between the dependent and various independent variables among physicians in Mekelle city 
2016(N=50). 





Sex Male 34(73.9) 12(26.1) 0.307 
 Female 2(50.0) 2(50.0) 
Marital Status Married 20(71.4) 8(28.6) 0.919 
 Single 16(72.7) 627.3 ( 
Religion  Orthodox 31(70.5) 13(29.5) 0.352 
 Muslim 1(50.0) 1(50.0) 
 Protestant 4(100.0) 0(0) 
Educational status First degree (GP) 16(44.4) 3(15.8) 0.250 
 Specialist 15(41.7) 7(31.8) 
 Other specify (Resident or HO) 5(13.9) 4(44.4) 
 
DISCUSSIONS 
From the current study 72% of physicians claimed that 
they always prescribe generic medicine, which is 
slightly lower than the study finding in Ghana which 
revealed 79.2 % of medicines prescribed by generic 
name, the reason for the difference of the two finding 
may be a study conducted in Ghana only consider 
antibiotic but the current study couldn't specify medicine 
group, the other study conducted in Jordan depicted that  


















Disagree Neutral Agree Strongly 
agree 
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often) prescribe generic medicine instead of an 
originator brand which is comparable with our 
findings.
35,36
 In the current study, 28% of physician 
claimed that brand medicines are safer than generic 
medicine which is comparable with one systematic 
review that showed a greater proportion of doctors 
(836/2928, 28.54%, 95%) believed that generic 
medicines are equally safer with brand medicine. In this 
review significantly higher proportion of physicians 
held the view that generic drugs were less effective than 
their brand name equivalents (1450/5056; 28.68%) but 
in the current study, 34% of physician's couldn't accept 
locally produced medicines as equally effective as 
original brand medicines.  Their view on the quality 
profile of the medicine might be the reason for such 
response.
8 
One study done in Nigeria depicted that 105 
(68.2%) respondents would prefer to recommend 
generic medicines over branded ones, while 49 (31.8%) 
respondents preferred to recommend branded medicines 
over generics in their practice.
37
 The current study 
reported 11.4% of the participants claimed that generic 
medicines are similar to a brand counterpart in all 
aspects but 80.2% couldn't accept this similarity. A 
study conducted in Pakistan Punjab showed 53% 
physicians consider the Socio-economic status of the 
patient to prescribe medicine, a similar study reported 
35% of a physician at Khyber Pakhtonkhwe(KPK).
38
 In 
the current study, 52% of the study participants believed 
that they were prescribed brand medicines on the basis 
of purchasing power of the patients which is comparable 
with that of Punjab and higher than KPK's finding. 
Another study in Malaysia revealed cost of drugs 
31(88.6%) and socio-economics status of the patients 
16(45.7%) are factors that influences clinicians 
prescribing intent; this is lower than that of the current 
study likewise, the study was done in Jordan showed 
58.5% of physician's believed that the cost is important, 
10.6% believed that the cost is highly important, 
whereas 30.9% of the physicians believed that the cost 
is not important at all but the result of Jordan study also 
a bit higher than from that of our study.
35,39
 The 
difference in study participants, sample size and 
medicine specification could be the probable reason for 
the difference in findings. From the current study above 
half 27 (58%) of the physicians strongly agreed or 
agreed that they prescribe brand medicines due to the 
medical representative influence which is higher than 
the study conducted previously in similar study area 
which reports 40 (48.2%) of the physicians believed that 
their prescribing behaviors were influenced by visits of 
MRs and reports from Kentucky physicians indicated 
that they used information supplied by pharmaceutical 
representatives in their clinical practice 5.4% daily, 
31.3% weekly, 47.7% monthly, and 14.4% yearly.
31,40 
A 
systematic review that scrutinizes this area figure out all 
randomized control trials (100 %) showed non-
significant differences between generic and brand-name 
drugs. The aggregate effect size was 0.01 (95 % CI -
0.05; 0.08) for soft outcomes; -0.06 (95 % CI -0.71; 
0.59) for hard outcomes, both indicating no difference 
between generic and brand-name drugs. Much the same 
results were observed for each drug class and in each 
stratified meta-analysis.
1 
But, in our study, only 11.4% 
of participants believed generic medicines are similar to 
a brand counterpart in all aspects. In the current study 
67.5% of the participants prescribe generic medicine due 
to their quality profile of medicine which is higher than 
from the findings that reported from Greek, that indicate 
half of the physicians characterize the quality of 
generics in terms of efficacy, safety and effectiveness as 




This study implies those socio-demographic factors of 
physicians like sex, marital status, religion and 
educational status has had no significant association 
with generic prescribing behavior, on contrary to our 
findings the report of Greek revealed Physician's age 
and opinion on generics' efficacy and effectiveness were 
identified as important determinants of their prescribing 
decisions and reports from university of Maryland 
showed differences in both the propensity of physicians 
to prescribe generics and in physicians' experiences may 
arise because of differences in the institutional features 
of where physicians practice (urban versus rural, group 
versus single practice, etc.) or because of the 
demographic characteristics of physicians (age, place of 




A possible limitation of this study could be the study 
population used for this study was very small. Second, 
this survey was conducted only among Physicians 
working in private health facilities in the Mekelle city. 
Therefore, the generalizability to physicians practicing 
in other facilities is somewhat limited. Third, the study 
is a cross-sectional type and thus it did not investigate 
cause and effect relationship. Nevertheless, this survey 
can serve as a preliminary study and is helpful in 
understanding the belief of Physicians on issues 
pertaining to generic medicines use in Ethiopia. 
CONCLUSION  
In conclusion the majority of physicians do not have a 
positive perception of generic medicines and a 
significant portion of the physician’s belief brand 
medicines safer and effective than generic counterparts. 
The main factors affecting the prescription of generic 
medicines by physicians have been identified in this 
study: the availability of medicines in pharmacies, low 
cost of medicines and the basis of purchasing power of 
the patients. 
Acknowledgments: The authors acknowledge the 
support of the Department of Pharmacy, College of 
Health Sciences, Mekelle University, in facilitating the 
data collection process. We are thankful for Physicians 
who participated in the study and private health facilities 
in Mekelle for their willingness in the data collection 
process. 
Disclosure: No fund was gained in the conduct of this 
study. Authors have declared that no competing interests 
exist. 
 
Workneh et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2017; 7(2):44-49                                       
ISSN: 2250-1177                                                                               [49]                                                                        CODEN (USA): JDDTAO 
REFERENCES  
1. Manzoli L. Flacco ME. Boccia S. et al. Generic versus brand-
name drugs used in cardiovascular diseases. Eur J Epidemiol. 
2016; 31:351-368. 
2. World Health Organization: Trade, foreign policy, diplomacy and 
health: generic drugs. 
 http://www.who.int/trade/glossary/story034/en/ (accessed January 
8, 2013). 
3. Auta A, Bala ET, Shalkur D. Generic medicine substitution: a 
cross-sectional survey of the perception of pharmacists in north-
central, Nigeria. Medical Principles and Practice. 2013; 23(1):53-
8.  
4. World Health Organization. Globalization (2004), Trade and 
Health, Available from: http://www.who.int/trade/glossary/story 
034/en/index.html. 
5. Homedes N, Ugalde A. Multisource drug policies in Latin 
America: survey of 10 countries. Bulletin of the World Health 
Organization. 2005; 83(1): 64–70. 
6. Chong CP, Hassali MA, Bahari MB, etal.Evaluating community 
pharmacists’ perceptions of future generic substitution policy 
implementation: a national survey from Malaysia. Health Policy. 
2010; 94: 68–75. 
7. Cameron A, Mantel-Teeuwisse AK, Leufkens HGM, 
etal.Switching from originator brand medicines to generic 
equivalents in selected developing countries: how much could be 
saved? Value Health. 2012; 15: 664–673. 
8. Colgan S, Faasse K, Martin LR, Stephens MH, Grey A, Petrie KJ. 
Perceptions of generic medication in the general population, 
doctors and pharmacists: a systematic review. BMJ open. 2015; 
5(12):e008915.  
9. Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, 
Choudhry NK. Physician perceptions about generic drugs. Annals 
of Pharmacotherapy. 2011; 45(1):31-8.  
10. Ferner R, Lenney W, Marriott J, et al. Controversy over generic 
substitution. BMJ.2010; 340:c1341–3. 
11. Johnston A, Asmar R, Dahlöf B, et al. Generic and therapeutic 
substitution: a viewpoint on achieving best practice in Europe. 
British journal of clinical pharmacology. 2011; 72(5):727-30.  
12. Jacobzone S. Pharmaceutical Policies in OECD Countries: 
Reconciling Social and Industrial Goals. Paris: OECD; 2000. 
13. Garattini L, Tediosi F. A comparative analysis of generics markets 
in five European countries. Health Policy. 2000; 51(3):149–162. 
14. DanzonPM, Chao LW. Cross-national price differences for 
pharmaceuticals: how large, and why? J Health Econ. 2000; 
19(2):159–195. 
15. Danzon PM, Chao LW. Does regulation drive out competition in 
pharmaceutical markets? J Law Econ. 2000; 43:311–357.  
16. King DR, Kanavos P: Encouraging the use of generic 
medicines.implications for transition economies. Croatian 
Medical. 2002; 43(4): 462–9. 
17. Haas JS, Phillips KA, Gerstenberger EP, SegerAC.Potential 
savings from substituting generic drugs for brand-name drugs: 
medical expenditure panel survey, 1997–2000. Annals of Internal 
Medicine.2005; 142(11):891–7. 
18. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs 
about generic drugs among elderly adults in hospital-based 
primary care practices. Patient education and counseling. 2008; 
73(2):377-83. 
19. Awaisu A, Kheir N, Ibrahim MI, El-Hajj M, Hazi H, Khudair N, 
Barazi R. Knowledge, attitudes, and practices of community 
pharmacists on generic medicines in Qatar. International journal 
of clinical pharmacy. 2014; 36(2):394-404.  
20. Cameron A, Mantel-Teeuwisse AK, Leufkens HG, Laing RO. 
Switching from originator brand medicines to generic equivalents 
in selected developing countries: how much could be saved? 
Value in Health. 2012 Aug 31; 15(5):664-73.  
21. Food, Medicine and Healthcare Administration and Control 
Authority of Ethiopia: Standard Treatment Guidelines for General 
Hospital; Addis Ababa Ethiopia.3rded. Addis Ababa; 2014, 
Available at:   
http://apps.who.int/medicinedocs/documents/s21694en/s21694en.
pdf 
22. World Health Organization. Pakistan - Medicine prices, 
availability, affordability and pricecomponents. 
Availablefrom:http://www.haiweb.org/medicineprices/ surveys 
/200407PK/sdocs/Pakistan-summary-report-web.pdf. Accessed 
June 20, 2016. 
23. Jamshed SQ, Ibrahim MI, Hassali MA, et al. Perception and 
attitude of general practitioners regarding generic medicines in 
Karachi, Pakistan: A questionnaire based study. Southern med 
review. 2012; 5(1):22-30. 
24. Profile c. pharmaceutical country profile. 201. Available from: 
http://www.who.int/medicines/areas/coordination/pakistan.pdf. 
Accessed June 24, 2016. 
25. Zaidi S, Bigdeli M, Aleem N, Rashidian A. Access to essential 
medicines in Pakistan: policy and health systems research 
concerns. PloS one. 2013 May 22; 8(5):e63515. 
26. Abratt R, Lanteigne J. Factors influencing general practitioners in 
the prescription of homeopathic medicines. South African Journal 
of Business Management. 2000; 31(3). 
27. Bakthavathsalam G. Generic drugs: cost effective alternate to 
branded drugs. Health Admin. 2006;19(1):16-9.  
28. Moss G, Schuiling I. A brand logic for pharma?: A possible 
strategy based on FMCG experience. Journal of Medical 
Marketing: Device, Diagnostic and Pharmaceutical Marketing. 
2004; 4(1):55-62. 
29. Seiter A. A practical approach to pharmaceutical policy. World 
Bank Publications; 2010.  
30. El-Dahiyat F, Kayyali R, Bidgood P. Physicians’ perception of 
generic and electronic prescribing: A descriptive study from 
Jordan. Journal of pharmaceutical policy and practice. 2014; 
7(1):1. 
31. Workneh BD, Gebrehiwot MG, Bayo TA, et al. Influence of 
Medical Representatives on Prescribing Practices in Mekelle, 
Northern Ethiopia. PloS one. 2016; 11(6):e0156795. 
32.  Roberts MJ. Pharmaceutical reform: a guide to improving 
performance and equity. World Bank Publications; 2011. 
33. Scherer FM. Pricing, profits and technological progress in the 
pharmaceutical industry. J Econ Perspect.1993; 7(3): 97–115. 
34. Wang H, Li N, Zhu H, Xu S, Lu H, Feng Z. Prescription pattern 
and its influencing factors in Chinese county hospitals: a 
retrospective cross-sectional study. PLoS One. 2013; 8(5):e63225.  
35. El-Dahiyat F, Kayyali R, Bidgood P. Physicians’ perception of 
generic and electronic prescribing: A descriptive study from 
Jordan. Journal of pharmaceutical policy and practice. 2014; 
7(1):1.  
36. Ahiabu MA, Tersbøl BP, Biritwum R, Bygbjerg IC, Magnussen P. 
A retrospective audit of antibiotic prescriptions in primary health-
care facilities in Eastern Region, Ghana. Health policy and 
planning. 2015 Jun 4:czv048 
37. Auta A, Bala ET, Shalkur D. Generic medicine substitution: a 
cross-sectional survey of the perception of pharmacists in north-
central, Nigeria. Medical Principles and Practice. 2013; 23(1):53-
8. 
38. Riaz H, Godman B, Hussain S, Malik F, Mahmood S, Shami A, 
Bashir S. Prescribing of bisphosphonates and antibiotics in 
Pakistan: challenges and opportunities for the future. Journal of 
Pharmaceutical Health Services Research. 2015; 6(2):111-21. 
39. Akter SF, Rani MF, Rahman JA, Nordin MS, Satwi S, Awang 
MB. Antimicrobial use and factors influencing prescribing in 
medical wards of a tertiary care hospital in Malaysia. Int J Sci 
Environ Technol. 2012; 1(4):274-84. 
40. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, 
pharmaceutical sales representatives, and the cost of prescribing. 
Archives of Family Medicine.1996; 5(4):201-6. 
41. Tsiantou V, Zavras D, Kousoulakou H, Geitona M, Kyriopoulos J. 
Generic medicines: Greek physicians’ perceptions and prescribing 
practices. Journal of clinical pharmacy and therapeutics. 2009; 
34(5):547-54. 
42. Hellerstein JK. The importance of the physician in the generic 
versus trade-name prescription decision. The Rand journal of 
economics. 1998:108-36. 
 
